Teladoc Health (TDOC) Expected to Announce Earnings on Wednesday

Teladoc Health (NYSE:TDOC - Get Free Report) is projected to post its Q3 2025 results after the market closes on Wednesday, October 29th. Analysts expect Teladoc Health to post earnings of ($0.26) per share and revenue of $625.6640 million for the quarter. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS.Investors may visit the the company's upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Wednesday, October 29, 2025 at 5:00 PM ET.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.27) by $0.08. The firm had revenue of $631.90 million during the quarter, compared to analysts' expectations of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The company's revenue for the quarter was down 1.6% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.38) EPS. On average, analysts expect Teladoc Health to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Teladoc Health Stock Performance

Shares of NYSE TDOC opened at $8.66 on Wednesday. The stock's 50-day moving average is $8.03 and its 200 day moving average is $7.64. The stock has a market cap of $1.53 billion, a price-to-earnings ratio of -7.28 and a beta of 1.90. Teladoc Health has a 1-year low of $6.35 and a 1-year high of $15.21. The company has a current ratio of 2.67, a quick ratio of 2.58 and a debt-to-equity ratio of 0.70.

Institutional Investors Weigh In On Teladoc Health

A number of large investors have recently added to or reduced their stakes in TDOC. Envestnet Asset Management Inc. bought a new position in shares of Teladoc Health during the second quarter valued at about $89,000. NewEdge Advisors LLC increased its holdings in Teladoc Health by 1,278.7% during the 1st quarter. NewEdge Advisors LLC now owns 11,305 shares of the health services provider's stock valued at $90,000 after purchasing an additional 10,485 shares during the period. Manhattan West Asset Management LLC purchased a new position in Teladoc Health during the 2nd quarter valued at about $100,000. Corient Private Wealth LLC raised its position in Teladoc Health by 30.4% during the 2nd quarter. Corient Private Wealth LLC now owns 17,180 shares of the health services provider's stock valued at $149,000 after purchasing an additional 4,004 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its holdings in Teladoc Health by 58.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 22,481 shares of the health services provider's stock worth $196,000 after buying an additional 8,254 shares during the period. Institutional investors own 76.82% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have commented on TDOC. Citigroup lifted their price target on shares of Teladoc Health from $9.50 to $10.50 and gave the stock a "neutral" rating in a research note on Tuesday. Mizuho initiated coverage on shares of Teladoc Health in a report on Friday, July 25th. They set a "neutral" rating and a $10.00 target price on the stock. Weiss Ratings reiterated a "sell (d-)" rating on shares of Teladoc Health in a research report on Wednesday, October 8th. Zacks Research upgraded shares of Teladoc Health from a "hold" rating to a "strong-buy" rating in a research report on Friday, October 10th. Finally, Evercore ISI raised their price objective on Teladoc Health from $8.00 to $9.00 and gave the company an "in-line" rating in a research note on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $9.97.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.